Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Flatt

Showing results (151-160 of 325) with videos related to

Pageof 33
Sort By:
Biochemical and Biophysical Research Communications|December 28, 2010
Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptideBarry D Kerr, Anneliese J S Flatt, Peter R Flatt, et al.
Molecular and Cellular Endocrinology|October 13, 2018
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonistsGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Diabetes/Metabolism Research and Reviews|July 15, 2020
Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1<sup>Cre/+</sup> ;Rosa26-eYFP miceNeil Tanday, R Charlotte Moffett, Victor A Gault, et al.
European Journal of Pharmacology|April 23, 2020
Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activitiesGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Biochemical Pharmacology|March 31, 2022
GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic miceDipak Sarnobat, R Charlotte Moffett, Peter R Flatt, et al.
Pancreas|May 15, 2010
Comparison of insulin release from MIN6 pseudoislets and pancreatic islets of Langerhans reveals importance of homotypic cell interactionsCatriona Kelly, Hong Guo, Jane T McCluskey, et al.
Peptides|November 5, 2018
Glucagon-related peptides from phylogenetically ancient fish reveal new approaches to the development of dual GCGR and GLP1R agonists for type 2 diabetes therapyGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Current Pharmaceutical Design|December 8, 2004
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agentsBrian D Green, Victor A Gault, Finbarr P M O'harte, et al.
Plos One|June 14, 2014
Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancyR Charlotte Moffett, Srividya Vasu, Bernard Thorens, et al.
Protein and Peptide Letters|September 28, 2007
Insulin releasing properties of the temporin family of antimicrobial peptidesYasser H A Abdel-Wahab, Lamin Marenah, Peter R Flatt, et al.
Pageof 33

Showing results (151-160 of 325) with videos related to

Sort By:
Pageof 33
Biochemical and Biophysical Research Communications|December 28, 2010
Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptideBarry D Kerr, Anneliese J S Flatt, Peter R Flatt, et al.
Molecular and Cellular Endocrinology|October 13, 2018
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonistsGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Diabetes/Metabolism Research and Reviews|July 15, 2020
Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1<sup>Cre/+</sup> ;Rosa26-eYFP miceNeil Tanday, R Charlotte Moffett, Victor A Gault, et al.
European Journal of Pharmacology|April 23, 2020
Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activitiesGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Biochemical Pharmacology|March 31, 2022
GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic miceDipak Sarnobat, R Charlotte Moffett, Peter R Flatt, et al.
Pancreas|May 15, 2010
Comparison of insulin release from MIN6 pseudoislets and pancreatic islets of Langerhans reveals importance of homotypic cell interactionsCatriona Kelly, Hong Guo, Jane T McCluskey, et al.
Peptides|November 5, 2018
Glucagon-related peptides from phylogenetically ancient fish reveal new approaches to the development of dual GCGR and GLP1R agonists for type 2 diabetes therapyGalyna V Graham, J Michael Conlon, Yasser H Abdel-Wahab, et al.
Current Pharmaceutical Design|December 8, 2004
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agentsBrian D Green, Victor A Gault, Finbarr P M O'harte, et al.
Plos One|June 14, 2014
Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancyR Charlotte Moffett, Srividya Vasu, Bernard Thorens, et al.
Protein and Peptide Letters|September 28, 2007
Insulin releasing properties of the temporin family of antimicrobial peptidesYasser H A Abdel-Wahab, Lamin Marenah, Peter R Flatt, et al.
Pageof 33